Gastrointestinal symptom control in palliative care (part 1);Gastroenterologische Symptomenkontrolle in der Palliativmedizin (Teil 1)

Gastroenterologe

Volumn 4, Issue 1, 2009, Pages 64-73

  Holtmann, M H ^a   Siepmann, U ^a   Mahlkow, S ^a   Domagk, D ^b   Pott, G ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c Medizinische Klinik Gastroenterologie und Palliativmedizin   (Germany)

Author keywords

Gastroenterology; Palliative care; Primary care; Symptom control; Terminal phase

Indexed keywords

EID: 68049129325     PISSN: 18619681     EISSN: 1861969X     Source Type: Journal    
DOI: 10.1007/s11377-008-0253-3     Document Type: Article

References (37)

1. Aabom B, Kragstrup J, Vondeling H et al (2006) Does persistent involvement by the GP Improve palliative care at home for end-stage cancer patients? Palliat Med 20:507-512
2. Bagg J, Sweeney MP, Lewis MA et al (2003) High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Palliat Med 17:477-481
3. Brazil K, Bedard M, Willison K (2002) Factors associated with home death for individuals who receive home support services: a retrospective cohort study. BMC Palliat Care 1:2
4. Bruera E, Belzile M, Neumann C et al (2000) A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage 19:427-435
5. Bruera E, Moyano JR, SaIa R et al (2004) Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial. J Pain Symptom Manage 28: 381-388
6. Critchley P, Plach N, Grantham M et al (2001 ) Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative patient: a systematic review. J Pain Symptom Manage 22:631-634
7. Davies A (2003) Oral medicine. Palliat Med 17: 554-555
8. Doyle D, Hanks G, Cherny N et al (2005) Oxford textbook of palliative medicine. Oxford University Press
9. Eilers J (2004) Nursing interventions and supportive care for the prevention and treatment of oral mucositis associated with cancer treatment. Oncol Nurs Forum 31:13-23
10. Eilers J, Berger AM, Petersen MC (1988) Development, testing and application of the oral assessment guide. Oncol Nurs Forum 15:325-330
11. Hardy J, Daly S, McQuade B et al (2002) A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients. Support Care Cancer 10:231-236
12. Herrstedt J (2008) Antiemetics: an update and the MASCC guidelines applied in clinical practice. Nat Clin Pract Oncol 5:32-43
13. Hesketh PJ (2008) Chemotherapy-induced nausea and vomiting. N Engl J Med 358:2482-2494
14. Heyland DK, Dodek P, Rocker G et al (2006) What matters most in end-of-life care: perceptions of seriously ill patients and their family members. CMAJ 174:627-633
15. Holm AN, Baron TH (2007) Palliative use of percutaneous endoscopic gastrostomy and percutaneous endoscopic cecostomy tubes. Gastrointest Endose Clin North Am 17:795-803
16. Holtmann MH, Domagk D, Weber M et al (2008) Gastroenterological palliative care. Z Gastroenterol 46:712-724
17. Johnson JT, Ferretti GA, Nethery WJ et al (1993) Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 329:390-395
18. McNicol E, Horowicz-Mehler N, Fisk RA et al (2003) Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 4:231-256
19. Miller M, Kearney N (2001) Oral care for patients with cancer: a review of the literature. Cancer Nurs 24:241-254
20. Naeim A, Dy SM, Lorenz KA et al (2008) Evidencebased recommendations for cancer nausea and vomiting. J Clin Oncol 26:3903-3910
21. Pearse H, Saxby C, Hicks F et al (2005) Patient choice regarding place of death. Palliat Med 19: 171-172
22. Pott G (2007) Ethik am Lebensende. Schattauer, Stuttgart
23. Rhodes VA, McDaniel RW (2001) Nausea, vomiting and retching: complex problems in palliative care. CA Cancer J Clin 51:232-248 quiz 249-252
24. Rosenquist A, Bergman K, Strang P (1999) Optimizing hospital-based home care for dying cancer patients: a population-based study. Palliat Med 13: 393-397
25. Saxby C, Ackroyd R, Callin S et al (2007) How should we measure emesis in palliative care? Palliat Med 21:369-383
26. ShIh A, Jackson KC 2nd (2007) Role of corticosteroids in palliative care. J Pain Palliat Care Pharmacother21:69-76
27. Smith HS, Busracamwongs A (2003) Management of hiccups in the palliative care population. Am J Hosp Palliat Care 20:149-154
28. Sweeney MP, Bagg J (2000) The mouth and palliative care. Am J Hosp Palliat Care 17:118-124
29. Sweeney MP, Bagg J, Baxter WP et al (1997) Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliat Med 11 : 225-232
30. Tegeler ML, Baumrucker SJ (2008) Gabapentin for intractable hiccups in palliative care. Am J Hosp Palliat Care 25:52-54
31. Tramer MR, Carroll D, Campbell FA et al (2001 ) Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 323:16-21
32. Turhal NS, Erdal S, Karacay S (2000) Efficacy of treatment to relieve mucositis-induced discomfort. Support Care Cancer 8:55-58
33. Vissink A, s-Gravenmade EJ, Panders AK et al (1983) A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes. Int J Oral Surg 12:232-238
34. Wllcock A,Twycross R (1996) Midazolam for intractable hiccup. J Pain Symptom Manage 12:59-61
35. Wilcock A, Twycross R (2006) Symptom management in palliative care: optimizing drug treatment. Br J Hosp Med 67:400-403
36. Wilkes JD (1998) Prevention and treatment of oral mucositis following cancer chemotherapy. Semin Oncol 25:538-551
37. Worthington HV, Clarkson JE, Eden OB (2006) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev CD000978